3 Vital Investment Priorities

3 Vital Investment Priorities

The aim of this report is to leverage government, industry and community support for an evidence based complementary medicines sector.

The investment areas and key issues identified include:

  1. Research - How can Australia capture the health benefits of complementary medicines?
    Commit 1% of NHMRC project funds annually ($8m pa) to complementary medicine research priorities and capacity building 2014-2018.
  1. InnovationHow can Australia support and encourage greater industry-led investment in R&D? Establish a Working Group to consider and implement key incentives that encourage greater industry-led investment in R&D to improve productivity, grow exports and increase employment opportunities.
  1. Communication and Policy DevelopmentHow can we ensure that we support relevant national research priorities, develop appropriate policy, and that research is translated into better health choices for consumers? Seek continued matching support for NICM over 2014-18 period from government, disease foundations, private sector and other stakeholders.

Review the full report:  Complementary Medicine: 3 Vital Investment Priorities (PDF, 606.68 KB)  (opens in a new window)